08/26/2026 | Press release | Distributed by Public on 08/27/2026 05:58
DeepScribe
Boris Pasche, M.D., Ph.D., FACP, president and CEO of the Barbara Ann Karmanos Cancer Institute, joined the Beyond the Chart: Exploring the AI Frontier for Oncology podcast to describe how he discovered the effects of electromagnetic radiofrequency waves on cancer, how this led to the invention of the TheraBionic P1 device, the process of getting a therapy device FDA-approved, using AI in oncology, how Karmanos is leading cancer care innovation, and more.